Winfried M. K. Amoaku

Safety and Efficacy of a Flexible Dosing Regimen of Ranibizumab in Neovascular Age-Related Macular Degeneration: The SUSTAIN Study

Frank G. Holz, Winfried M. K. Amoaku, Robyn H. Guymer et al. · Ophthalmology · 2011 · 410 citations

Ocular Disease, Ophthalmology, Medicine +5

Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial

Sobha Sivaprasad, A Toby Prevost, Joana C. Vasconcelos et al. · The Lancet · 2017 · 372 citations · Full text

Diabetic Retinopathy, Ocular Disease, Retina +7

Radiation retinopathy—Clinical, histopathological, ultrastructural and experimental correlations

D. B. Archer, Winfried M. K. Amoaku, Tom A. Gardiner · Eye · 1991 · 259 citations · Full text

Experimental Correlations, Radiation Medicine, Ocular Disease +5

Prevalence of glaucoma in an African population

C T Ntim-Amponsah, Winfried M. K. Amoaku, S Ofosu-Amaah et al. · Eye · 2004 · 175 citations · Full text

Ophthalmology, Eye Health, Glaucoma +3

Ranibizumab in Myopic Choroidal Neovascularization: The 12-Month Results from the REPAIR Study

Adnan Tufail, Nirodhini Narendran, Praveen J. Patel et al. · Ophthalmology · 2013 · 106 citations

Ocular Disease, Ophthalmology, Pathology +5